Abstract
AbstractProstate cancer (PCa) is a common malignant tumor in men, when the disease progresses to the advanced stage, most patients will develop distant metastasis and develop into castration-resistant prostate cancer (CRPC), resulting in increased mortality. Ubiquitination is a widespread protein post-translational modification process in the biological world, and it plays an important role in the development and transfer of PCa. E3 ubiquitin ligase plays an important role in the specific selection and role of substrates in the process of ubiquitination ligase. This review will briefly introduce the ubiquitination process and E3 ubiquitin ligase, focus on the recently discovered multiple mechanisms by which ubiquitination affects PCa development and metastasis, and a summary of the current emerging proteolysis-targeting chimeras (PROTAC) in the treatment of PCa.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference111 articles.
1. Siegel, R. L., Miller, K. D., & Fuchs, H. E. et al. (2021). Cancer Statistics, 2021. CA: A Cancer Journal of Clinicians, 71(1), 7–33.
2. Dalela, D., Sun, M., & Diaz, M. et al. (2019). Contemporary trends in the incidence of metastatic prostate cancer among US men: Results from nationwide analyses. European Urology Focus, 5(1), 77–80.
3. Ketchandji, M., Kuo, Y. F., & Shahinian, V. B. et al. (2009). Cause of death in older men after the diagnosis of prostate cancer. Journal of the American Geriatrics Society, 57(1), 24–30.
4. Kollmeier, M. A., & Zelefsky, M. J. (2012). How to select the optimal therapy for early-stage prostate cancer. Critical Reviews in Oncology/Hematology, 83(2), 225–234.
5. Komura, K., Sweeney, C. J., & Inamoto, T. et al. (2018). Current treatment strategies for advanced prostate cancer. International Journal of Urology, 25(3), 220–231.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献